# IDEXX LABORATORIES INC /DE (IDXX) FY2026 Q2 Balance Sheet

- Company: IDEXX LABORATORIES INC /DE (IDXX)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-04, accession number 0000874716-26-000123
- Page: https://plicit.ai/financials/idxx/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/idxx-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 3,442,335,000 US dollars
- **Current assets**: 1,509,489,000 US dollars
- **Non-current assets**: 1,932,846,000 US dollars
- **Liabilities**: 1,829,760,000 US dollars
- **Current liabilities**: 1,287,665,000 US dollars
- **Non-current liabilities**: 542,095,000 US dollars
- **Equity**: 1,612,575,000 US dollars
- **Accounts receivable, net**: 627,083,000 US dollars
- **Inventories**: 391,579,000 US dollars
- **Other current assets**: 293,894,000 US dollars
- **Cash and cash equivalents**: 196,933,000 US dollars
- **Property and equipment, net**: 733,238,000 US dollars
- **Other long-term assets**: 567,729,000 US dollars
- **Goodwill**: 410,946,000 US dollars
- **Operating lease right-of-use assets**: 122,764,000 US dollars
- **Intangible assets, net**: 98,169,000 US dollars
- **Credit Facility**: 519,000,000 US dollars
- **Accrued liabilities**: 453,169,000 US dollars
- **Current portion of long-term debt**: 149,999,000 US dollars
- **Accounts payable**: 129,097,000 US dollars
- **Current portion of deferred revenue**: 36,400,000 US dollars
- **Long-term debt, net of current portion**: 299,865,000 US dollars
- **Long-term operating lease liabilities, net of current portion**: 100,502,000 US dollars
- **Other long-term liabilities**: 56,504,000 US dollars
- **Deferred income tax liabilities**: 52,638,000 US dollars
- **Long-term deferred revenue, net of current portion**: 32,586,000 US dollars
- **Retained earnings**: 7,008,760,000 US dollars
- **Additional paid-in capital**: 1,910,290,000 US dollars
- **Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 108,717 shares in 2026 and 108,369 shares in 2025; Outstanding: 78,874 shares in 2026 and 79,712 shares in 2025**: 10,872,000 US dollars
- **Deferred stock units: Outstanding: 26 units in 2026 and 59 units in 2025**: 5,938,000 US dollars
- **Treasury stock, at cost: 29,843 shares in 2026 and 28,657 shares in 2025**: negative 7,259,747,000 US dollars
- **Accumulated other comprehensive loss**: negative 63,538,000 US dollars
- **Gross equity (calculated)**: 8,935,860,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.